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Abstract
Glycolipoprotein (GLP) from pathogenic serovars of Leptospira
has been implicated in the pathogenesis of leptospirosis by its
presence in tissues of experimental animals with leptospirosis, the
inhibition of the Na,K-ATPase pump activity, and induced produc-
tion of cytokines. The aims of the present study were to investi-
gate the induction of IL-6 by GLP in peripheral blood mononuclear
cells (PBMC) and to demonstrate monocyte stimulation at the
cellular level in whole blood from healthy volunteers. PBMC were
stimulated with increasing concentrations (5 to 2500 ng/ml) of GLP
extracted from the pathogenic L. interrogans serovar Copenhage-
ni, lipopolysaccharide (positive control) or medium (negative con-
trol), and supernatants were collected after 6, 20/24, and 48 h, and
kept at -80ºC until use. Whole blood was diluted 1:1 in RPMI
medium and cultivated for 6 h, with medium, GLP and lipopolysac-
charide as described above. Monensin was added after the first
hour of culture. Supernatant cytokine levels from PBMC were
measured by ELISA and intracellular IL-6 was detected in mono-
cytes in whole blood cultures by flow-cytometry. Monocytes were
identified in whole blood on the basis of forward versus side
scatter parameters and positive reactions with CD45 and CD14
antibodies. GLP (≥50 ng/ml)-induced IL-6 levels in supernatants
were detected after 6-h incubation, reaching a peak after 20/24 h.
The percentage of monocytes staining for IL-6 increased with
increasing GLP concentration. Thus, our findings show a GLP-
induced cellular activation by demonstrating the ability of GLP to
induce IL-6 and the occurrence of monocyte activation in whole
blood at the cellular level.
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Leptospirosis is a zooanthroponosis caused
by pathogenic spirochetes of the genus Lep-
tospira. Infection with these microorganisms
may be nonsymptomatic or result in different
clinical conditions ranging from a “flu-like”
disease with low morbidity to the severe or
icteric form, also known as Weil’s syndrome,
which clinically resembles sepsis (1-3).
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Circulating levels of tumor necrosis fac-
tor alpha (TNF-α) have been detected in
patients with leptospirosis and are associated
with the severity of the disease (4). Interleu-
kin-10 (IL-10) levels were also elevated but
were not associated with the severity of the
disease in our previous work and a high IL-
10/TNF-α ratio was related to a better prog-
nosis, suggesting that the anti-inflammatory
response may be protective (5).
Several cellular components of L. inter-
rogans, such as lipoproteins, lipopolysac-
charide (LPS) and glycolipoprotein (GLP),
are toxic and may participate in the pathogen-
esis of the disease (6). In experimental mod-
els with guinea pigs injected with pathogenic
L. interrogans, GLP can be detected in the
damaged tissues adhering to endothelial cells
and to epithelial membranes, accompanying
other antigen deposits resulting from bacte-
rial destruction by the immune system (7-9).
Therefore, the GLP complex may contain
toxins involved in the pathogenesis of lep-
tospirosis. In rabbit renal tubule epithelial
cells, GLP inhibits sodium-potassium ATP-
ase (Na,K-ATPase) pump activity in a dose-
dependent manner, a finding that may explain
some electrolytic alterations observed in lep-
tospirosis patients with acute renal failure
(10). In a previous study we demonstrated
that GLP could induce the production of
TNF-α and IL-10 in peripheral blood mono-
nuclear cells (PBMC) from healthy volun-
teers (11), although the cellular source of
cytokines was not demonstrated.
The aims of the present study were to
investigate the induction of IL-6 by GLP in
PBMC and to demonstrate monocyte stimu-
lation at the cellular level in whole blood from
healthy volunteers.
GLP was extracted from the pathogenic
L. interrogans serovar Copenhageni obtained
from a patient with Weil’s syndrome by the
method described by Vinh et al. (6). LPS
from Salmonella abortus equi (kindly sup-
plied by Dr. C. Galanos, Max Planck Institute
of Immunobiology, Freiburg, Germany) was
separated by the phenol-water method and
purified by the phenol-chloroform-petroleum
ether method (12). The study was approved
by the University Ethics Committee and 18
healthy volunteers were included in the study
after giving written informed consent to
participate.
For the ELISA experiments, 10 ml of
peripheral venous blood was collected into
heparin treated-tubes (Becton-Dickinson,
Franklin Lakes, NJ, USA) and PBMC were
obtained by the Ficoll gradient method (Ficoll-
Paque, Amersham Pharmacia Biotech, Upp-
sala, Sweden) and adjusted to 2 x 106 cells/
ml. PBMC were cultivated in RPMI 1640
medium (Sigma, St. Louis, MO, USA) supple-
mented with 10% fetal calf serum (HyClone,
Logan, UT, USA) on 24-well plates (Nunclon;
Nalge Nunc Int., Roskilde, Denmark). Cells
were stimulated with 10 ng/ml LPS and 5,
50, 500, and 2500 ng/ml GLP. Supernatants
were collected at 6, 20/24, and 48 h of
incubation and stored at -80ºC until use.
IL-6 was measured by capture ELISA.
Antibody pairs and reagents were obtained
from PharMingen (San Diego, CA, USA).
Samples were tested in duplicate and a stan-
dard curve with human recombinant cy-
tokine was constructed for each plate. Tests
were performed according to manufacturer
instructions.
For the detection of intracellular IL-6 in
whole blood, 1 ml of blood was diluted 1:1 in
RPMI and incubated with 100 ng/ml LPS
(positive control) and 5, 50, 250, and 500 ng/
ml GLP, or without a stimulus (negative
control) for 1 h at 37ºC in 5% CO2. Monensin
(Sigma) was added in a concentration of 2
µM and the samples were further incubated
for 5 h. Monoclonal antibodies were obtained
from Becton Dickinson Immunocytometry
Systems (BDIS, San Jose, CA, USA). The
clones used, all obtained from BDIS, were:
TNF-α-fluorescein isothiocyanate (FITC),
clone 6401.1111; CD14-perinidin chloro-
phyll protein (PerCP), cloneMφP9; IL-6-
phycoerythrin (PE), clone AS12; CD45-allo-
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phycocyanin O (APC), clone HI30. After
incubation, CD14-PerCP and CD45-APC
were added for 15 min at room temperature
in the dark. Red blood cells were lysed,
samples were washed with 2 ml PBS, resus-
pended in 1 ml fixation buffer (PBS and 4%
paraformaldehyde (Polyscience, Warrington,
PA, USA), pH 7.4-7.6, and left to stand for
20 min at 4ºC in the dark. The tubes were
centrifuged, the supernatants discarded, and
the cells resuspended in 0.3 ml staining
buffer (PBS with 1% FCS (Gibco, Gaithers-
burg, MD, USA), 0.1% sodium azide (Sigma),
pH 7.4-7.6, and stored at 4oC in the dark
overnight. Cells were centrifuged and the
supernatant was discarded. Samples were
stained with 20 µl monoclonal anti-IL-6-PE
and 5 µl monoclonal TNF-α-FITC for 30
min at 4ºC in the dark, washed in 2 ml
permeabilization buffer, resuspended in 0.3
ml staining buffer, and analyzed with a
FACSCalibur flow-cytometer (BDIS).
Data acquisition and analyses were per-
formed using CellQuest software (BDIS).
Peripheral blood cells were acquired and
monocytes were gated on the basis of CD14
and CD45 positivity and forward versus side
scatter parameters. For each condition,
10,000 events were acquired. TNF-α- and
IL-6-positive cells were reported as the per-
centage of monocytes (Figure 1).
The kinetics and dose-response of GLP-
induced IL-6 in PBMC were determined.
Induction of IL-6 was obtained with GLP
concentrations of 50 ng/ml or higher (P ≥
0.05 GLP versus control). GLP-induced IL-
6 secretion was detected after 6 h of incuba-
tion, reaching a peak between 6 and 24 h of
incubation and remaining stable after 48 h
(Figure 2A).
Intracellular detection of IL-6 in mono-
cytes was demonstrated after stimulating
whole blood with GLP and LPS. The per-
centage of IL-6-positive monocytes increased
with increasing GLP doses (Figure 2B).
In a previous study, we demonstrated
that GLP extracted from the pathogenic L.
interrogans serovar Copenhageni could in-
duce PBMC activation. This was demon-
strated by the secretion of TNF-α and IL-10
and the increase in the expression of CD69
and HLA-DR, markers of cellular activation.
In the present study, we confirm and expand
these results by demonstrating the secretion
of IL-6 and monocyte activation at the cellu-
lar level in whole blood, through the intracel-
lular detection of this cytokine.
LPS, peptidoglycan, and phospholipase
are among the toxic components of L. inter-
rogans that may play a role in the pathogen-
esis of leptospirosis (6,13-15). Lipoproteins
are also potential toxic factors in leptospiro-
sis as well as in other spirochetal diseases.
Lipoproteins are recognized to be the most
abundant proteins in spirochetes and are
involved in disease pathogenesis through
their ability to trigger the host inflammatory
response (16). Expression of leptospiral lipo-
proteins Lip L32 and Lip L41 was demon-
strated by immunohistochemistry of kidney
tissue following infection with virulent L.
kirschneri. Treponemal and Borrelial lipo-
proteins are capable of activating monocytes
in vitro and cellular activation has been
shown to involve CD14 and Toll-like recep-
tor 2 molecules (16-18).
GLP is likely to be involved in the patho-
genesis of the disease as suggested by the
presence of GLP in damaged tissues of
patients and experimental animals (19). More-
over, it was demonstrated that this compo-
nent might block the tubular epithelial cell
sodium pump in the kidneys (10). This may
be one of the mechanisms of renal dysfunc-
tion that is characteristic of the disease.
Other toxic effects exerted by GLP may be
observed in cultures of Vero and L929 cells,
leading to cell membrane perforations fol-
lowed by cell death (6).
The toxic effects of bacterial compounds,
such as the Gram-negative outer membrane
LPS, are mediated by the interaction with
host cells, with a central role for macrophag-
es (12). Macrophage-derived cytokines, such
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Figure 1. Detection of intracel-
lular cytokines in monocytes
following whole blood stimula-
tion with GLP. Whole blood was
stimulated for 6 h with LPS,
GLP or not, the last 5 h in the
presence of monensin. Mono-
cytes were gated combining
the forward scatter versus side
scatter parameters, with a gate
over the cells with low to inter-
mediate size and granularity
(R1), and CD14- and CD45-
stained cells (R2) (A), and the
TNF-α- and IL-6-stained cells
are reported as the percent-
age of monocytes (B). Quad-
rant statistics were established
using cells with isotype mono-
clonal antibodies. GLP = glyco-
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as TNF-α and IL-6, are considered to be
mediators of LPS toxicity, yet fundamental
for the host defense against microorganisms
(12). Circulating levels of TNF-α have been
demonstrated in patients with leptospirosis
and their presence is associated with poor
outcomes (4). The presence of IL-6 in PBMC
supernatants following GLP stimulation ex-
Figure 2. Kinetics of IL-6 release (A) and detection of IL-6 in monocytes in whole blood after stimulation with GLP (B). A, LPS was used as positive
control. Peripheral blood mononuclear cells were stimulated with either Salmonella abortus equi LPS or Leptospira interrogans serovar
Copenhageni GLP at the doses indicated and incubated for 48 h. Supernatants were collected after 6, 20/24, and 48 h and IL-6 was measured
by ELISA. Results are reported as the mean ± SD for three to five experiments. GLP = glycolipoprotein; LPS = lipopolysaccharide. GLP (≥50 ng/
ml) versus control: P < 0.05 for 6 and 20/24 h and P = 0.08 for 48 h (Mann-Whitney test). B, The cytokine-producing cells are reported as the
percentage of monocytes. Data are reported as means ± SD for six experiments. *P < 0.05 versus control (Mann-Whitney test).
pands the array of cytokines induced by this
toxin. The detection of intracellular IL-6 in
monocytes following whole blood stimula-
tion with GLP is a direct demonstration of
monocyte activation and provides evidence
for the participation of GLP in the pathogen-
esis of leptospirosis.
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